# PLx Pharma

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/plx-pharma

- Industry: Pharmaceuticals
- Headquarters: Houston, US
- Website: www.plxpharma.com
- Total disclosed funding: $4.1M
- Latest round: Series C (Mar 14, 2007)
- Investors on record: 1

## About

Founded in 2002 and based in Texas, US, PLx Pharma Inc. is a pharmaceutical firm that develops Vazalore 325 mg, a liquid-filled aspirin that makes use of a lipid and fatty acid-based targeted release technology called the PLxGuard delivery system which enables selective release of the drug based on pH levels and bile acid contents in the gastrointestinal (GI) tract while reducing the risk of cardiovascular and gastrointestinal complications.

## Funding rounds

- Series C, Mar 14, 2007, $4.1M — Integra Ventures

## Investors

- Integra Ventures (https://capitalatlas.ai/funds/integra-ventures) — Series C